Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Morepen Laboratories
|
Panacea Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.5 % | 0.87 % | 5.51 % |
|
Financials
|
|||
|
5 yr Average ROE
|
20.08 % | 13.75 % | 17.16 % |
|
5yr average Equity Multiplier
|
1.4 | 1.84 | 1.61 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 1.34 | 0.4 |
|
5yr Avg Net Profit Margin
|
11.59 % | 5.42 % | 19.26 % |
|
Price to Book
|
6.79 | 3.09 | 4.14 |
|
P/E
|
19.65 | 27.23 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-64.92 Days | 21.38 Days | -102.87 Days |
|
Inventory Days
|
63.34 Days | 53.55 Days | 109.97 Days |
|
Days Receivable
|
25.32 Days | 63.5 Days | 37.7 Days |
|
Days Payable
|
145.09 Days | 98.41 Days | 294.14 Days |
|
5yr Average Interest Coverage Ratio
|
17.66 | 39.33 | 2.9 |
|
5yr Avg ROCE
|
27.52 % | 15.84 % | -1.68 % |
|
5yr Avg Operating Profit Margin
|
19.26 % | 8.37 % | -1.99 % |
|
5 yr average Debt to Equity
|
0.02 | 0.04 | 0.05 |
|
5yr CAGR Net Profit
|
24.75 % | 23.42 % | -64.03 % |
|
5yr Average Return on Assets
|
14.44 % | 7.36 % | 6.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 35.65 % | 72.48 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.88 % | -2.73 % | -1.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.53 % | 0.0 | 0.0 |
|
RPG Life Sciences
|
Morepen Laboratories
|
Panacea Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|